Pharmaceutical capacity and supply chain, affordable medicine dominate July lobbying
Pharmascience Inc.’s lobbying of unelected government officials about pharmaceutical industry issues made it the busiest advocacy group during an otherwise slow July, according to the federal lobbyists’ registry.
